Celcuity Inc. financial data

Symbol
CELC on Nasdaq
Industry
Services-Medical Laboratories
Location
16305 36 Th Avenue N, Suite 100, Minneapolis, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
Celcuity LLC (to 9/15/2017)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.23K % -37%
Debt-to-equity 57.5 % +50%
Return On Equity -62.7 % -27.5%
Return On Assets -39.8 % -12%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.1M shares +53.4%
Common Stock, Shares, Outstanding 37.1M shares +65.9%
Common Stock, Value, Issued 37.1K USD +65.9%
Weighted Average Number of Shares Outstanding, Basic 42.8M shares +93.5%
Weighted Average Number of Shares Outstanding, Diluted 42.8M shares +93.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 88.8M USD +67.2%
General and Administrative Expense 7.75M USD +54.3%
Operating Income (Loss) -96.6M USD -66.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -94M USD -66.3%
Net Income (Loss) Attributable to Parent -94M USD -66.3%
Earnings Per Share, Basic -2.61 USD/shares +4.4%
Earnings Per Share, Diluted -2.61 USD/shares +15.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.6M USD -51.1%
Other Assets, Current 8.38M USD
Assets, Current 272M USD +92.2%
Property, Plant and Equipment, Net 339K USD +51.7%
Operating Lease, Right-of-Use Asset 260K USD -42.2%
Assets 273M USD +91.8%
Accounts Payable, Current 9.16M USD +62.5%
Accrued Liabilities, Current 17M USD +146%
Liabilities, Current 26.3M USD +107%
Operating Lease, Liability, Noncurrent 95.7K USD -64.7%
Liabilities 123M USD +149%
Retained Earnings (Accumulated Deficit) -235M USD -66.5%
Stockholders' Equity Attributable to Parent 150M USD +61.2%
Liabilities and Equity 273M USD +91.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.1M USD -32.6%
Net Cash Provided by (Used in) Financing Activities 14.1M USD +20627%
Net Cash Provided by (Used in) Investing Activities 3.54M USD -83.8%
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 37.1M shares +65.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 870K USD +16.5%
Deferred Tax Assets, Valuation Allowance 36.1M USD +59.9%
Operating Lease, Liability 411K USD +62.6%
Depreciation 29.6K USD -32.7%
Payments to Acquire Property, Plant, and Equipment 89.7K USD +1183%
Lessee, Operating Lease, Liability, to be Paid 508K USD +83.8%
Property, Plant and Equipment, Gross 2.09M USD +5.62%
Operating Lease, Liability, Current 175K USD -6.84%
Lessee, Operating Lease, Liability, to be Paid, Year Two 220K USD +217%
Lessee, Operating Lease, Liability, to be Paid, Year One 214K USD +3.18%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +25%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 97.2K USD +311%
Lessee, Operating Lease, Liability, to be Paid, Year Three 74.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 8.46M USD +20.1%
Preferred Stock, Shares Issued 318K shares -70.1%
Preferred Stock, Shares Authorized 2.5M shares 0%
Additional Paid in Capital 385M USD +64.4%
Preferred Stock, Shares Outstanding 318K shares -70.1%
Interest Expense 8.4M USD +82.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%